Related Experiment Video
Updated: Jun 12, 2025
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Exposing the Masquerade of Nocardia otitidiscaviarum Pneumonia: A Case Report
Sandhya Nallamotu1, Mahith S Reddy1
1Department of Medicine, Kasturba Medical College, Manipal, Manipal, IND.
Abstract:
We present a rare case of an immunocompetent 49-year-old male agriculturalist from India diagnosed with Nocardia otitidiscaviarum pneumonia. Nocardia species are ubiquitous gram-positive, partially acid-fast bacilli that predominantly infect immunocompromised individuals. Only 0.3% to 2.9% of all nocardiosis cases are attributed to N. otitidiscaviarum. The patient presented with a 25-day history of wet cough and high-grade fever, with bilateral bronchial breath sounds on chest auscultation and findings consistent with pneumonia on chest X-ray. During hospitalization, multiple treatment revisions were made. On admission, empiric antibiotic therapy against community-acquired pneumonia was initiated. Later, GeneXpert sputum testing for Mycobacterium tuberculosis complex (MTBC) was positive for MTBC DNA. Suspected tuberculosis with a secondary infection prompted a treatment switch to antitubercular therapy (ATT) along with meropenem. Despite changes to treatment, the patient continued to deteriorate with no signs of clinical improvement. ATT with meropenem was discontinued when a repeat GeneXpert for MTBC was negative, ruling out tuberculosis. Slow-growing bronchial wash culture identified the rare pathogen N. otitidiscaviarum, prompting an urgent referral to a specialized Infectious Diseases team. Treatment was then tailored according to antibiotic resistance-sensitivity testing. Targeted multidrug antibiotic therapy with trimethoprim-sulfamethoxazole and amikacin against N. otitidiscaviarum facilitated gradual clinical improvement. This case underscores the importance of considering uncommon pathogens in differential diagnosis and highlights the critical role of microbiological diagnostics in guiding effective treatment. Drug resistance and changing bacterial pathogenicity trends must not be overlooked. The round-about antibiotic treatment changes in this case point to the necessity for faster diagnostic methods in identifying Nocardia species. Further research into rapid diagnostic methods and up-to-date treatment guidelines are warranted to optimize outcomes in nocardiosis management.
Insights
This case highlights a rare Nocardia otitidiscaviarum pneumonia in an immunocompetent patient. Prompt microbiological diagnosis and targeted therapy are crucial for effective Nocardia treatment.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Nocardia species are gram-positive, partially acid-fast bacilli, typically causing disease in immunocompromised individuals.
- Nocardia otitidiscaviarum infections are rare, accounting for only 0.3% to 2.9% of all nocardiosis cases.
- Pneumonia due to Nocardia species can mimic other respiratory infections, complicating diagnosis.
Observation:
- An immunocompetent agriculturalist presented with prolonged pneumonia symptoms, initially treated empirically.
- Initial diagnostic tests suggested tuberculosis (MTBC), leading to antitubercular therapy (ATT) and meropenem, but the patient's condition worsened.
- Sputum cultures eventually identified Nocardia otitidiscaviarum, necessitating a change in treatment strategy.
Findings:
- The patient's pneumonia was caused by the rare pathogen Nocardia otitidiscaviarum.
- Targeted multidrug therapy with trimethoprim-sulfamethoxazole and amikacin, guided by antibiotic sensitivity testing, led to clinical improvement.
- The case emphasizes the diagnostic challenges posed by Nocardia species, especially in non-immunocompromised hosts.
Implications:
- This case underscores the importance of considering uncommon pathogens in the differential diagnosis of pneumonia, even in immunocompetent individuals.
- Accurate and timely microbiological diagnostics are critical for effective treatment of Nocardia infections.
- There is a need for faster diagnostic methods and updated treatment guidelines for Nocardia species to improve patient outcomes and address evolving drug resistance patterns.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:25Endocarditis II: Clinical features and Diagnostic Tests